25th week of 2021 patent applcation highlights part 30 |
Patent application number | Title | Published |
20210188778 | NOVEL POLYMORPHS OF 4-[3-CHLORO-4-(N'-CYCLOPROPYL UREIDO)PHENOXY]-7-METHOXYQUINOLINE-6-CARBOXAMIDE, ITS SALTS AND PROCESS FOR THE PREPARATION THEREOF | 2021-06-24 |
20210188779 | DITHIOESTER COMPOUND | 2021-06-24 |
20210188780 | DITHIOESTER COMPOUND | 2021-06-24 |
20210188781 | CANNABINOID RECEPTOR MODULATORS | 2021-06-24 |
20210188782 | BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS | 2021-06-24 |
20210188783 | SUBSTITUTED BENZIMIDAZOLES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR-BETA KINASE | 2021-06-24 |
20210188784 | 2-AMINO-2-(1,2,3-TRIAZOLE-4-YL)PROPANE-1,3-DIOL DERIVATIVE OF NOVEL COMPOUND FOR DIRECTLY INHIBITING ASM ACTIVITY, AND USE THEREOF | 2021-06-24 |
20210188785 | SULFAMATE DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, THEIR MEDICAL USE AND THE METHOD OF OBTAINING 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENYL SULFAMATE DERIVATIVES | 2021-06-24 |
20210188786 | SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE | 2021-06-24 |
20210188787 | DOTA COMPOUNDS AND USES THEREOF | 2021-06-24 |
20210188788 | REAGENT FOR MASS SPECTROMETRY | 2021-06-24 |
20210188789 | ISOXAZOLINE DERIVATIVES | 2021-06-24 |
20210188790 | ISOXAZOLE DERIVATIVES AS NUCLEAR RECEPTOR AGONISTS AND USES THEREOF | 2021-06-24 |
20210188791 | 2-AMINOARYL-5-ARYLOXAZOLE ANALOGS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2021-06-24 |
20210188792 | MYELINATION STIMULATOR COMPOUNDS, AND METHODS OF TREATMENT | 2021-06-24 |
20210188793 | CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME | 2021-06-24 |
20210188794 | PROCESS FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID DIALKYL ESTER | 2021-06-24 |
20210188795 | MULTI-STAGE ESTERIFICATION PROCESS | 2021-06-24 |
20210188796 | METHOD FOR DECOMPOSING FLAVONOID GLYCOSIDE AND METHOD FOR PRODUCING FLAVONOID | 2021-06-24 |
20210188797 | HEAT AND OXIDATION RESISTANT A9 TETRAHYDROCANNOBINOL (THC) AND CANNABINIOL (CBD) COMPOUND AND METHOD OF MANUFACTURING THE SAME | 2021-06-24 |
20210188798 | PROCESS FOR PRODUCING AN EXTRACT CONTAINING TETRAHYDROCANNABINOL AND CANNABIDIOL FROM CANNABIS PLANT MATERIAL, AND CANNABIS EXTRACTS | 2021-06-24 |
20210188799 | SYNTHESIS METHOD AND DEVICE FOR RAPIDLY PRODUCING LACTIDE AT HIGH YIELD | 2021-06-24 |
20210188800 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | 2021-06-24 |
20210188801 | CRYSTALLINE FORMS OF 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)NICOTINAMIDE | 2021-06-24 |
20210188802 | PROTEASOME ACTIVITY ENHANCING COMPOUNDS | 2021-06-24 |
20210188803 | PYRIDINYLMETHYLENEPIPERIDINE DERIVATIVES AND USES THEREOF | 2021-06-24 |
20210188804 | NOVEL POTASSIUM CHANNEL INHIBITORS | 2021-06-24 |
20210188805 | 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH | 2021-06-24 |
20210188806 | INDOLINE-1-FORMAMIDE COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF | 2021-06-24 |
20210188807 | COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS | 2021-06-24 |
20210188808 | COMPOUNDS AS NEURONAL HISTAMINE RECEPTOR-3 ANTAGONISTS AND USES THEREOF | 2021-06-24 |
20210188809 | IRAK4 INHIBITING AGENTS | 2021-06-24 |
20210188810 | HETEROARYL INHIBITORS OF PAD4 | 2021-06-24 |
20210188811 | ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | 2021-06-24 |
20210188812 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2021-06-24 |
20210188813 | EZH2 INHIBITOR AND PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC SUBSTANCES THEREOF, AND APPLICATION OF EZH2 INHIBITOR | 2021-06-24 |
20210188814 | PYRIDAZINONE COMPOUNDS AND USES THEREOF | 2021-06-24 |
20210188815 | CAPSID INHIBITORS FOR THE PREVENTION OF HIV | 2021-06-24 |
20210188816 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE | 2021-06-24 |
20210188817 | OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISORDERS AND SKIN DISEASES | 2021-06-24 |
20210188818 | INDAZOLYL-SPIRO[2.3]HEXANE-CARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | 2021-06-24 |
20210188819 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | 2021-06-24 |
20210188820 | ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | 2021-06-24 |
20210188821 | JAK1 SELECTIVE INHIBITORS | 2021-06-24 |
20210188822 | METHOD FOR PREPARING BENZOFURAN DERIVATIVE | 2021-06-24 |
20210188823 | Method for Producing Diarylpyridine Derivatives | 2021-06-24 |
20210188824 | SURFACTANTS FROM ALDEHYDES | 2021-06-24 |
20210188825 | COMPOUNDS CONTAINING POLYSUBSTITUTED BENZO[D][1,3]OXATHIOLE, BENZO[D][1,3]OXATHIOLE 3-OXIDE OR BENZO[D][1,3]OXATHIOLE 3,3-DIOXIDE AND METHODS/USES THEREOF AS AGONISTS OF G PROTEIN-COUPLED RECEPTOR 119 | 2021-06-24 |
20210188826 | COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME | 2021-06-24 |
20210188827 | ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | 2021-06-24 |
20210188828 | COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS | 2021-06-24 |
20210188829 | Chemical Compounds | 2021-06-24 |
20210188830 | SOLID FORMS OF AN SGC STIMULATOR | 2021-06-24 |
20210188831 | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | 2021-06-24 |
20210188832 | SECONDARY AMINE-SUBSTITUTED COUMARIN COMPOUNDS AND THEIR USES AS FLUORESCENT LABELS | 2021-06-24 |
20210188833 | COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY | 2021-06-24 |
20210188834 | Chiral Indole Compounds and Their Use | 2021-06-24 |
20210188835 | METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL | 2021-06-24 |
20210188836 | 6-AMINOPYRIDIN-3-YL THIAZOLES AS MODULATORS OF RORyT | 2021-06-24 |
20210188837 | NITROGEN-CONTAINING 6-MEMBERED CYCLIC COMPOUND | 2021-06-24 |
20210188838 | ANTI-BIOFILM COMPOUNDS | 2021-06-24 |
20210188839 | COMPOUNDS AND THEIR METHODS OF USE | 2021-06-24 |
20210188840 | NEW SUBSTITUTED AZAINDOLINE DERIVATIVES AS NIK INHIBITORS | 2021-06-24 |
20210188841 | ANALGESIC DRUG USING PAC1 RECEPTOR ANTAGONISTIC DRUG | 2021-06-24 |
20210188842 | AZA-INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES | 2021-06-24 |
20210188843 | QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS | 2021-06-24 |
20210188844 | FUSED PYRIMIDINE PYRIDINONE COMPOUNDS AS JAK INHIBITORS | 2021-06-24 |
20210188845 | SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS | 2021-06-24 |
20210188846 | 4,5-ANNULATED 1,2,4-TRIAZOLONES | 2021-06-24 |
20210188847 | 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS | 2021-06-24 |
20210188848 | DIAZASPIRO ROCK INHIBITORS | 2021-06-24 |
20210188849 | DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS B INFECTIONS | 2021-06-24 |
20210188850 | ORGANIC COMPOUNDS | 2021-06-24 |
20210188851 | BROAD-SPECTRUM CARBAPENEMS | 2021-06-24 |
20210188852 | COMPOUNDS AND THEIR METHODS OF USE | 2021-06-24 |
20210188853 | FUSED HETEROCYCLIC COMPOUND, PYRAZOLE-RING-CONTAINING FUSED HETEROCYCLIC COMPOUND, AGRICULTURAL COMPOSITION CONTAINING THEREOF, AND METHOD OF USING THE COMPOSITION | 2021-06-24 |
20210188854 | Amino-methyl Piperidine Derivative as Kinase Inhibitor | 2021-06-24 |
20210188855 | COMPOUNDS | 2021-06-24 |
20210188856 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | 2021-06-24 |
20210188857 | SOS1 INHIBITORS | 2021-06-24 |
20210188858 | Substituted Bicyclic Pyrimidine Compounds with Tubulin and Multiple Receptor Inhibition | 2021-06-24 |
20210188859 | CRYSTAL FORM OF ACP-196 AND METHOD OF TREATMENT THEREOF | 2021-06-24 |
20210188860 | 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | 2021-06-24 |
20210188861 | PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF PSORIASIS AND SYSTEMIC LUPUS ERYTHEMATOSUS | 2021-06-24 |
20210188862 | NEW PROCESS | 2021-06-24 |
20210188863 | INDAZOLYL-SPIRO[2.2]PENTANE-CARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | 2021-06-24 |
20210188864 | PRODUCTION METHOD OF DIOL | 2021-06-24 |
20210188865 | COMPOUND, PREPARATION METHOD AND USE THEREOF | 2021-06-24 |
20210188866 | METHOD FOR PREPARING HIGH-PURITY TOTAL GINKGOLIDE AND USE THEREOF | 2021-06-24 |
20210188867 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | 2021-06-24 |
20210188868 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF | 2021-06-24 |
20210188869 | INHIBITORS OF KRAS G12C | 2021-06-24 |
20210188870 | FUSED 1,4-OXAZEPINES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS | 2021-06-24 |
20210188871 | NITROGEN CONTAINING HETEROCYCLE SUBSTITUTED BENZOXAZINE OXAZOLIDINONE COMPOUND AND PREPARATION METHOD AND USE THEREOF | 2021-06-24 |
20210188872 | TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS | 2021-06-24 |
20210188873 | A Process for the Steroselective Preparation of Chiral 2-[(Hetero)Arylalkylsulfanyl]Pyrimidines and Products Obtainable Therefrom | 2021-06-24 |
20210188874 | HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE | 2021-06-24 |
20210188875 | OXAZINE COMPOUND AND APPLICATION THEREOF | 2021-06-24 |
20210188876 | FUSED TRICYCLIC RING DERIVATIVES AS SRC HOMOLOGY-2 PHOSPHATE INHIBITORS | 2021-06-24 |
20210188877 | TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS | 2021-06-24 |